Shifting Towards α V β 6 Integrin Ligands Using Novel Aminoproline‐Based Cyclic Peptidomimetics-Reference-Cited by-同舟云学术

Shifting Towards α V β 6 Integrin Ligands Using Novel Aminoproline‐Based Cyclic Peptidomimetics

Published:2020-09-21 Issue:59 Volume:26 Page:13468-13475
ISSN:0947-6539
Container-title:Chemistry – A European Journal
language:en
Short-container-title:Chem. Eur. J.

Author:

Bugatti Kelly¹^ORCID,Bruno Agostino¹^ORCID,Arosio Daniela²^ORCID,Sartori Andrea¹^ORCID,Curti Claudio¹^ORCID,Augustijn Lisa³^ORCID,Zanardi Franca¹^ORCID,Battistini Lucia¹^ORCID

Affiliation:

1. Dipartimento di Scienze degli Alimenti e del Farmaco Università di Parma Parco Area delle Scienze 27A 43124 Parma Italy

2. Istituto di Scienze e Tecnologie Chimiche (SCITEC) “Giulio Natta” CNR, Consiglio Nazionale delle Ricerche Via C. Golgi 19 20133 Milano Italy

3. Amsterdam Institute for Molecules, Medicines and Systems (AIMMS) Division of Medicinal Chemistry Vrije Universiteit Amsterdam De Boelelaan 1108, 1081 HZ Amsterdam Noord-Holland The Netherlands

Funder

Ministero dell’Istruzione, dell’Università e della Ricerca

Publisher

Wiley

Subject

General Chemistry,Catalysis,Organic Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/chem.202002554

Reference42 articles.

1. Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress

2. Principles in the design of ligand-targeted cancer therapeutics and imaging agents

3. The roles of integrin αvβ6 in cancer